MacroGenics
Business Services · Maryland, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9704 Medical Center Dr, Rockville, Maryl...Phone Number
(301) 251-5172Website
www.macrogenics.comRevenue
$175.1 MillionStock Symbol
MGNXIndustry
About MacroGenics
MacroGenics, Inc. is a publicly traded biotechnology company dedicated to discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The organization specializes in immuno-oncology and applies proprietary antibody engineering technologies to create medicines that enhance the immune system's ability to recognize and eliminate cancer cells. By integrating scientific research, translational medicine, clinical development, and biologics manufacturing, the company seeks to address significant unmet medical needs across multiple oncology indications.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: MGNXShow moreMacroGenics Org Chart
Compare Similar Companies to MacroGenics
Compare insights from companies similar to MacroGenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MacroGenics
$175.1M
201-500
Public
$559M
2000
JK
James KarrelsSenior Vice President, Chief Financial Officer and Secretary
$105M
201-500
Public
$237.2M
1997
CE
Celia EckertSenior Vice President, General Counsel & Corporate Secretary
MacroGenics Tech Stack
A closer look at the technologies used by MacroGenics
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MacroGenics
Sign Up For FreeTo access detailed company insights
MacroGenics, Inc. is a publicly traded biotechnology company dedicated to discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The organization specializes in immuno-oncology and applies proprietary antibody engineering technologies to create medicines that enhance the immun... Read More